Glucagon-like peptide-1 (GLP-1) receptor agonists in type 2 diabetes and long-term complications: FOCUS on retinopathy.
Diabet Med
; 38(1): e14390, 2021 01.
Article
em En
| MEDLINE
| ID: mdl-32799379
Palavras-chave
ACCORD; ADVANCE; Diabetic Retinopathy; ELIXA; EXSCEL; Eye events; FOCUS; GLP-1; Glucagon-like peptide-1 receptor agonists; HARMONY Outcomes; LEADER; Liraglutide; Lixisenatide; Long-term complications; Microvascular complications; PIONEER-6; REWIND; SUSTAIN-6; Semaglutide; Type 2 Diabetes; UKPDS; VADT; albiglutide; dulaglutide; exenatide; oral semaglutide
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Diabetes Mellitus Tipo 2
/
Retinopatia Diabética
/
Receptor do Peptídeo Semelhante ao Glucagon 1
/
Hipoglicemiantes
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article